James Nathanielsz
Net Worth
Last updated:
What is James Nathanielsz net worth?
The estimated net worth of Mr. James Nathanielsz is at least $47,160,297 as of 5 Jul 2013. He owns shares worth $40,063,422 as insider, has earned $60,105 from insider trading and has received compensation worth at least $7,036,770 in Propanc Biopharma, Inc..
What is the salary of James Nathanielsz?
Mr. James Nathanielsz salary is $541,290 per year as Executive Chairman, Chief Executive Officer, Chief Financial Officer, Treasurer & Sec. in Propanc Biopharma, Inc..
How old is James Nathanielsz?
Mr. James Nathanielsz is 51 years old, born in 1974.
What stocks does James Nathanielsz currently own?
As insider, Mr. James Nathanielsz owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | Executive Chairman, Chief Executive Officer, Chief Financial Officer, Treasurer & Sec. | 9,701,761 | $4.13 | $40,063,422 |
What does Propanc Biopharma, Inc. do?
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
James Nathanielsz insider trading
Propanc Biopharma, Inc.
Mr. James Nathanielsz has made 5 insider trades between 2012-2013, according to the Form 4 filled with the SEC. Most recently he sold 55,000 units of PPCB stock worth $5,005 on 5 Jul 2013.
The largest trade he's ever made was exercising 250,000 units of PPCB stock on 23 Aug 2012. As of 5 Jul 2013 he still owns at least 9,701,761 units of PPCB stock.
Propanc Biopharma key executives
Propanc Biopharma, Inc. executives and other stock owners filed with the SEC:
- Dr. Julian Norman Kenyon (77) Chief Scientific Officer & Director
- Mr. James Nathanielsz (51) Executive Chairman, Chief Executive Officer, Chief Financial Officer, Treasurer & Sec.